San Francisco, CA (PRWEB) May 19, 2014
Neural ID, the provider of the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle, today announced the appointment of Will Frederick as Chief Financial Officer. Mr. Frederick will report to Tim Carruthers, Chief Executive Officer.
Mr. Frederick will be responsible for executive management and oversight of all finance, accounting, legal and administrative operations for Neural ID. He joins Neural ID from Entelos, where he served as Chief Financial Officer. Prior to Entelos, Mr. Frederick’s nearly 25 years of experience includes serving as CFO of the Global Communications Solutions division at Avaya Inc, as well as CFO roles at NovaRay Medical, Pharsight Corp., and Versata Inc.
“It is a pleasure to welcome Will to our executive management team,” said Mr. Carruthers. “Will has a proven record of developing and implementing strategies to drive revenue growth, increase profitability and obtain corporate objectives. His extensive life science software experience further strengthens our executive team as we continue to drive Neural ID’s growth strategy.”
About Neural ID
Neural ID provides the only collaborative biosignal analytics platform spanning the pharmaceutical lifecycle. From Discovery through Clinical and Health Information, Neural ID delivers a scalable enterprise solution addressing the industry’s productivity crisis. Our flagship product, IWS delivers expert-driven machine learning, massive data reduction and an interoperable data format to help customers make better decisions faster, leading to increased product revenues and reduced development costs. Neural ID, based in Redwood City, CA, launched IWS in 2013. Further information is available at http://www.neuralid.com.